Vaziri Farahani K; Romanazzi S; Palazzini M; Negro L; Presotto L; Marinelli A; Gambetti S; Leci E; Manes A; Galie N; Branzi A., Regressione delle alterazioni elettrocardiografiche indicative di ipertrofia ventricolare destra nei pazienti con ipertensione arteriosa polmonare., in: , «ITALIAN HEART JOURNAL», 2005, 6, pp. 174 - 174 (atti di: 66 Congresso della Società Italiana di Cardiologia, Roma, 10-13 Dicembre 2005) [Abstract]
Manes A; Rocchi G; Ferlito M; Vaziri Farahani K; Romanazzi S; Negro L; Palazzini M; Presotto L; Marinelli A; Gambetti S; Leci E; Galie N; Branzi A, Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida., in: , «ITALIAN HEART JOURNAL», 2005, 6, pp. 85 S - 85 S (atti di: 66 Congresso della Societa Italiana di Cardiologia, Roma, 10-13 Dicembre 2005) [Abstract]
Galiè, Nazzareno; Ghofrani, Hossein A.; Torbicki, Adam; Barst, Robyn J.; Rubin, Lewis J.; Badesch, David; Fleming, Thomas; Parpia, Tamiza; Burgess, Gary; Branzi, Angelo; Grimminger, Friedrich; Kurzyna, Marcin; Simonneau, Gérald, Sildenafil citrate therapy for pulmonary arterial hypertension, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2005, 353, pp. 2148 - 2157 [Scientific article]
Seibold J; Badesch D; Galie N; Langleben D; Naeije R; Simonneau G; Barst R, Sitaxsentan, a selective endothelin-A receptor antagonist, improves exercise capacity in pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD), in: , «CHEST», 2005, 128, pp. 219s - 219s (atti di: American College of Chest Physician 2005 Congress, Montreal-Canada, October 29-November 3 2005) [Abstract]
Seibold JR; Langleben D; Badesch D; Naeije E; Simonneau G; Galie N; Barst RJ, Sitaxsentan, a selective endothelin-A receptor antagonist, improves exercise capacity in pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD)., in: , «ARTHRITIS AND RHEUMATISM», 2005, 52, pp. s282 - s282 (atti di: American College of Rheumatology 2005 Congress, San Diego, 12-17 November) [Abstract]
Badesch D; Galie N; Langleben D; Naeije R; Simonneau G; Barst R, Sitaxsentan improves time to clinical worsening in patients with pulmonary arterial hypertension, in: , «CHEST», 2005, 128, pp. 160 - 161 (atti di: American College of Chest Physicians Annual Congress 2005, Montreal- Quebec- Canada, October 29- 3 November) [Abstract]
Badesch D; Galie N; Langleben D; Naeije R; Simonneau G; Barst RJ, Sitaxsentan improves time to clinical worsening in patients with pulmonary arterial hypertension (PAH)., in: , «ARTHRITIS AND RHEUMATISM», 2005, 52, pp. s167 - s167 (atti di: American College of Rheumatology 2005 Congress, San Diego, 12-17 November) [Abstract]
Galie N; Langleben D; Badesch D; Frost A; Lawrence EC; Naeije R Simonneau G;
Barst R., STRIDE-2 Trial: a placebo-controlled study for sitaxsentan in pulmonary arterial hypertension, in: , «EUROPEAN HEART JOURNAL», 2005, 26, pp. 112 - 113 (atti di: Congresso Società Europea di Cardiologif, Stoccolma, 3-7 SEPTEMBER 2005) [Abstract]
Sitbon O; McLaughlin VV; Badesch DB; Barst RJ; Black C; Galie N; Humbert M; Rainisio M; Rubin LJ; Simonneau G., Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol., «THORAX», 2005, 60, pp. 1025 - 1030 [Scientific article]
McLaughlin VV; Sitbon O; Badesch DB; Barst RJ; Black C; Galie N; Rainisio M; Simonneau G; Rubin LJ., Survival with first-line bosentan in patients with primary pulmonary hypertension., «EUROPEAN RESPIRATORY JOURNAL», 2005, 24, pp. 353 - 359 [Scientific article]
Oudiz RJ; Schilz RJ; Barst RJ; Galie N; Rich S; Rubin LJ; Simonneau G, Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease., «CHEST», 2005, 126, pp. 420 - 427 [Scientific article]
Simonneau G; Galie N; Rubin LJ; Langleben D; Seeger W; Domenighetti G; Gibbs S; Lebrec D; Speich R; Beghetti M; Rich S; Fishman A., Clinical classification of pulmonary hypertension., «JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY», 2004, 43, pp. 5s - 12s [Scientific article]
Humbert M; Barst RJ; Robbins IM; Channick RN; Galie N; Boonstra A; Rubin LJ; Horn EM; Manes A; Simonneau G, Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2., «EUROPEAN RESPIRATORY JOURNAL», 2004, 24, pp. 353 - 359 [Scientific article]
Galie N; Seeger W; Naeije R; Simonneau G; Rubin LJ., Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension., «JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY», 2004, 43, pp. 81s - 88s [Scientific article]
Vaziri Farahani K; Boggian G; Manes A; Pelino F; Romanazzi S; Palazzini M; Negro L; Galie N; Branzi A., Effetti a lungo termine del trattamento con bosentan sulla capacità funzionale e sui parametri emodinamici nei pazienti con ipertensione arteriosa polmonare., in: , «ITALIAN HEART JOURNAL», 2004, 5, pp. 201s - 201s (atti di: 55 Congresso della Società Italiana di Cardiologia, Roma, 11-15 Dicembre 2004) [Abstract]
